(CercleFinance.com) – Futures on the main US indices (+ 0.3% on the S & P500, + 0.5% on the Nasdaq-100) point to an opening on the right foot for equity indices, after a weekend of three days due to closure Friday to Christmas Eve.
In the absence of major macroeconomic data, the stock market news of the coming days could once again be punctuated by the file of the Covid-19 pandemic and the consequences of the Omicron variant on the economic recovery.
‘The cancellation of several thousand flights in the United States on Sunday as well as the return to port, according to several media, of at least three cruise ships due to cases of Covid-19 on board are fueling concerns’, underlines- do we also at Kiplink Finance.
However, some confidence continues to prevail in this case, after preliminary data from various studies, published last week, showing that Omicron remains less likely to lead to hospitalizations than Delta.
In securities news, Merck and Ridgeback announced on Friday that they had received special emergency approval in Japan for molnupiravir, their investigational drug for infectious diseases caused by SARS-CoV-2.
Boeing said it won a contract worth more than $ 239 million from the US military to re-engine Apache attack helicopters assembled by the aeronautics and defense giant.
Copyright (c) 2021 CercleFinance.com. All rights reserved.